263 related articles for article (PubMed ID: 1775129)
21. Functional characterizations of the androgen receptor confirm that the molecular basis of androgen action is transcriptional regulation.
Rundlett SE; Wu XP; Miesfeld RL
Mol Endocrinol; 1990 May; 4(5):708-14. PubMed ID: 2274054
[TBL] [Abstract][Full Text] [Related]
22. The retinoic acid receptor-beta 2 contains two separate cell-specific transactivation domains, at the N-terminus and in the ligand-binding domain.
Folkers GE; van der Leede BJ; van der Saag PT
Mol Endocrinol; 1993 Apr; 7(4):616-27. PubMed ID: 8389001
[TBL] [Abstract][Full Text] [Related]
23. A point mutation in the second zinc finger of the DNA-binding domain of the androgen receptor gene causes complete androgen insensitivity in two siblings with receptor-positive androgen resistance.
Mowszowicz I; Lee HJ; Chen HT; Mestayer C; Portois MC; Cabrol S; Mauvais-Jarvis P; Chang C
Mol Endocrinol; 1993 Jul; 7(7):861-9. PubMed ID: 8413310
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of androgen receptor (AR) function by the reproductive orphan nuclear receptor DAX-1.
Holter E; Kotaja N; Mäkela S; Strauss L; Kietz S; Jänne OA; Gustafsson JA; Palvimo JJ; Treuter E
Mol Endocrinol; 2002 Mar; 16(3):515-28. PubMed ID: 11875111
[TBL] [Abstract][Full Text] [Related]
25. Multiple androgen response elements and a Myc consensus site in the androgen receptor (AR) coding region are involved in androgen-mediated up-regulation of AR messenger RNA.
Grad JM; Dai JL; Wu S; Burnstein KL
Mol Endocrinol; 1999 Nov; 13(11):1896-911. PubMed ID: 10551783
[TBL] [Abstract][Full Text] [Related]
26. Evidence that lack of ligand-binding domain correlates with nuclear distribution of unliganded human androgen receptor and loss of transactivation activity.
Suzuki N; Imai A
Gynecol Endocrinol; 2011 Nov; 27(11):940-3. PubMed ID: 21501000
[TBL] [Abstract][Full Text] [Related]
27. A role of the amino-terminal (N) and carboxyl-terminal (C) interaction in binding of androgen receptor to chromatin.
Li J; Fu J; Toumazou C; Yoon HG; Wong J
Mol Endocrinol; 2006 Apr; 20(4):776-85. PubMed ID: 16373397
[TBL] [Abstract][Full Text] [Related]
28. A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. Requirement for the DNA-binding domain and modulation by NH2-terminal and carboxyl-terminal sequences.
Zhou ZX; Sar M; Simental JA; Lane MV; Wilson EM
J Biol Chem; 1994 May; 269(18):13115-23. PubMed ID: 8175737
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional activation by TR3 receptor, a member of the steroid receptor superfamily.
Kokontis J; Liao S; Chang C
Receptor; 1991; 1(4):261-70. PubMed ID: 1843211
[TBL] [Abstract][Full Text] [Related]
30. The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor.
Haelens A; Tanner T; Denayer S; Callewaert L; Claessens F
Cancer Res; 2007 May; 67(9):4514-23. PubMed ID: 17483368
[TBL] [Abstract][Full Text] [Related]
31. Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability.
Zhou ZX; Lane MV; Kemppainen JA; French FS; Wilson EM
Mol Endocrinol; 1995 Feb; 9(2):208-18. PubMed ID: 7776971
[TBL] [Abstract][Full Text] [Related]
32. Protein inhibitor of activated STAT-1 (signal transducer and activator of transcription-1) is a nuclear receptor coregulator expressed in human testis.
Tan J; Hall SH; Hamil KG; Grossman G; Petrusz P; Liao J; Shuai K; French FS
Mol Endocrinol; 2000 Jan; 14(1):14-26. PubMed ID: 10628744
[TBL] [Abstract][Full Text] [Related]
33. Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone.
Culig Z; Stober J; Gast A; Peterziel H; Hobisch A; Radmayr C; Hittmair A; Bartsch G; Cato AC; Klocker H
Cancer Detect Prev; 1996; 20(1):68-75. PubMed ID: 8907206
[TBL] [Abstract][Full Text] [Related]
34. Identification of 3',5'-cyclic adenosine monophosphate response element and other cis-acting elements in the human androgen receptor gene promoter.
Mizokami A; Yeh SY; Chang C
Mol Endocrinol; 1994 Jan; 8(1):77-88. PubMed ID: 8152432
[TBL] [Abstract][Full Text] [Related]
35. Substitution of aspartic acid-686 by histidine or asparagine in the human androgen receptor leads to a functionally inactive protein with altered hormone-binding characteristics.
Ris-Stalpers C; Trifiro MA; Kuiper GG; Jenster G; Romalo G; Sai T; van Rooij HC; Kaufman M; Rosenfield RL; Liao S
Mol Endocrinol; 1991 Oct; 5(10):1562-9. PubMed ID: 1775137
[TBL] [Abstract][Full Text] [Related]
36. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.
Culig Z; Hobisch A; Cronauer MV; Cato AC; Hittmair A; Radmayr C; Eberle J; Bartsch G; Klocker H
Mol Endocrinol; 1993 Dec; 7(12):1541-50. PubMed ID: 8145761
[TBL] [Abstract][Full Text] [Related]
37. Modulation of androgen receptor transcriptional activity by the estrogen receptor.
Kumar MV; Leo ME; Tindall DJ
J Androl; 1994; 15(6):534-42. PubMed ID: 7721655
[TBL] [Abstract][Full Text] [Related]
38. Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity.
Elhaji YA; Stoica I; Dennis S; Purisima EO; Lumbroso R; Beitel LK; Trifiro MA
Hum Mol Genet; 2006 Mar; 15(6):921-31. PubMed ID: 16449235
[TBL] [Abstract][Full Text] [Related]
39. Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity.
Thompson J; Saatcioglu F; Jänne OA; Palvimo JJ
Mol Endocrinol; 2001 Jun; 15(6):923-35. PubMed ID: 11376111
[TBL] [Abstract][Full Text] [Related]
40. The androgen receptor ligand-binding domain stabilizes DNA binding in living cells.
Farla P; Hersmus R; Geverts B; Mari PO; Nigg AL; Dubbink HJ; Trapman J; Houtsmuller AB
J Struct Biol; 2004 Jul; 147(1):50-61. PubMed ID: 15109605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
